Financial Performance - The company reported a net profit loss attributable to shareholders for the years 2018, 2019, and 2020, indicating ongoing performance risks [5]. - The company's operating revenue for 2020 was ¥163,309,323.59, a decrease of 28.69% compared to ¥229,005,660.26 in 2019 [25]. - The net profit attributable to shareholders in 2020 was ¥4,211,925.94, a significant turnaround from a loss of ¥60,790,981.91 in 2019, representing a 106.93% increase [25]. - The net cash flow from operating activities improved to ¥13,682,992.18 in 2020, a 139.16% increase from -¥34,937,173.07 in 2019 [25]. - The total assets at the end of 2020 were ¥907,019,358.37, down 20.67% from ¥1,143,399,156.92 at the end of 2019 [25]. - The company's basic earnings per share for 2020 was ¥0.01, compared to a loss of ¥0.19 per share in 2019, marking a 107.08% improvement [25]. - The weighted average return on net assets was 2.77% in 2020, a significant recovery from -34.03% in 2019 [25]. - The company reported a net profit excluding non-recurring gains and losses of -¥18,794,092.71 in 2020, an improvement of 81.22% from -¥100,087,031.59 in 2019 [25]. - In Q4 2020, the net profit attributable to shareholders was ¥7,260,134.35, showing a positive trend after three quarters of losses [27]. Shareholder and Dividend Information - The company will not distribute cash dividends or issue bonus shares for the current fiscal year [12]. - The total cash dividend amount for 2020 was 0.00, which represents 0.00% of the total profit distribution [119]. - The company reported a negative distributable profit for 2018 and 2019, resulting in no cash dividends or capital reserve transfers during those years [117]. - The company has maintained a consistent policy of not distributing dividends during the last three fiscal years due to ongoing losses [117]. - The cash dividend amount for 2019 was also 0.00, with a net profit of -60,790,981.91 [119]. Risks and Legal Issues - The controlling shareholder, Tianshan Agricultural Development Co., Ltd., holds 18.35% of the company's shares, all of which are pledged, posing a high risk of liquidation due to unpaid debts [11]. - The company faces significant risks from animal diseases, which can severely impact production and profitability [7]. - The company is actively cooperating with law enforcement regarding ongoing fraud cases, aiming to minimize losses and protect investor rights [10]. - The company emphasizes the importance of investor awareness regarding potential risks associated with ongoing litigation and financial uncertainties [8]. - The company is exposed to disease risks in livestock farming, which can significantly impact production and profitability if outbreaks occur [106]. - The company is actively addressing legal issues related to a contract fraud case from 2018, with ongoing civil and criminal proceedings [68]. - The company has ongoing litigation regarding advertising rights, with no court judgment made as of the commitment date [125]. Business Strategy and Operations - The company plans to enhance market engagement and customer communication to improve performance and strengthen product competitiveness [5]. - The company is implementing new models to initiate fattening business as a new growth point to enhance risk resistance [6]. - The company is focusing on improving asset efficiency through leasing and disposal strategies to mitigate operational risks [6]. - The company aims to improve economic benefits for farmers by providing tailored breeding solutions based on genetic characteristics [35]. - The company is committed to the "Big Beef Cattle Strategy" over the next five years, focusing on breeding and expanding beef cattle fattening operations [58]. - The company plans to focus on beef cattle fattening in resource-rich regions such as Xinjiang, Shandong, and Inner Mongolia, aiming to establish standardized processes and improve facilities [51]. - The company aims to establish a traceability system for beef cattle to improve product quality and create a high-quality beef supply platform [52]. Market and Industry Trends - The average wholesale price of beef in 2020 was approximately 84.0 RMB/kg, a 14.7% increase compared to 2019, with a peak price of 85.57 RMB/kg in November 2020 [44]. - China's beef consumption reached 9.515 million tons in 2020, ranking second globally, with a per capita consumption of about 6.8 kg [44]. - The beef industry is transitioning from "incremental development" to "efficiency development," driven by strong domestic demand and supportive policies [43]. - The implementation of the "Grain to Feed" policy is expected to lower breeding costs and improve the economic efficiency of beef production [49]. Asset Management and Investments - The company has reduced fixed assets by 20.70% compared to the beginning of the period, mainly due to the disposal of subsidiaries and low-efficiency idle assets [53]. - The company has increased investment in intelligent breeding technology, integrating breeding equipment with information technology to enhance the beef cattle industry [50]. - The company has increased investment properties by 533.18% compared to the beginning of the period, due to the transfer of leased assets [53]. - The company has committed to optimizing human resource allocation to enhance organizational efficiency [158]. Compliance and Governance - The company has committed to ensuring that all disclosures related to the transaction are truthful and complete [137]. - The company has a complete and independent corporate governance structure, ensuring that its shareholder meetings, board of directors, and supervisory board operate independently [133]. - The company has signed an agreement for a debt of 5 billion yuan, which is intended to support its capital increase [132]. - The company is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure, with an administrative penalty of 300,000 yuan imposed [163].

Financial Performance - Net profit attributable to shareholders of the listed company was CNY 4,599,678.41, an increase of 150.94% year-on-year [7]. - Operating revenue for the reporting period was CNY 22,954,049.40, representing a year-on-year increase of 29.20% [7]. - The net profit attributable to shareholders for the year-to-date period was CNY -3,048,208.41, a reduction in loss of CNY 24,594,048.32 compared to the same period last year [15]. - The company reported a weighted average return on equity of 3.04%, down from 7.93% in the previous year [7]. - The basic earnings per share for the reporting period was CNY 0.0147, an increase of 151.03% year-on-year [7]. - The company reported a net loss of CNY -3,048,208.41, an improvement of 88.97% compared to a loss of CNY -27,642,256.73 in the previous year, due to reduced expenses and gains from subsidiary disposals [21]. - The company achieved a net profit of 300 million CNY in Q3 2020, which is a 20% increase compared to the same period last year [47]. - The net profit for Q3 2020 was a loss of CNY 2,918,362.81, compared to a loss of CNY 26,945,703.51 in Q3 2019, indicating an improvement in performance [82]. Revenue and Costs - The company's operating revenue reached CNY 133,117,629.28, a 66.93% increase compared to CNY 79,742,648.16 in the same period last year, primarily due to the recognition of trade cattle business revenue [20]. - Operating costs amounted to CNY 116,128,985.80, reflecting an 82.59% increase from CNY 63,600,740.08 year-on-year, in line with the increase in operating revenue [20]. - Total operating revenue for Q3 2020 was CNY 22,954,049.40, an increase of 29.0% compared to CNY 17,766,209.92 in the same period last year [72]. - The total operating revenue for the third quarter was CNY 7,999,690.90, an increase from CNY 7,661,014.75 in the previous year, representing a growth of approximately 4.4% [76]. - The total operating costs decreased to CNY 26,349,064.51 from CNY 29,738,158.35, a reduction of about 11.5% [73]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 907,254,984.84, a decrease of 20.65% compared to the end of the previous year [15]. - The company’s total liabilities to assets ratio was 84.38% at the end of the reporting period [15]. - The company’s net assets attributable to shareholders decreased by 2.25% to CNY 145,854,235.10 compared to the beginning of the year [15]. - Total liabilities decreased to CNY 765,512,236.65 from CNY 996,652,347.46, a reduction of 23.2% [65]. - The company's total equity decreased to CNY 141,742,748.19 from CNY 146,746,809.46, a decline of 3.4% [66]. - Cash and cash equivalents dropped significantly to CNY 170,798.94 from CNY 11,243,080.14, a decrease of 98.5% [67]. - The total current assets decreased to ¥76,145,051.97 from ¥141,187,668.97, reflecting a substantial decline in asset liquidity [63]. Cash Flow - The net cash flow from operating activities was CNY -5,474,674.77, a decline of 120.09% compared to the previous year [7]. - The company's cash inflow from operating activities totaled CNY 89,040,203.71, a decrease of 64.43% compared to CNY 250,290,111.14 in the previous year, attributed to trade cattle business payment terms [22]. - Cash outflow from operating activities was CNY 94,024,571.83, down 62.67% from CNY 251,892,412.56 year-on-year, reflecting similar reasons as cash inflow [22]. - Operating cash inflow for the period was CNY 140,289,715.94, down 33.3% from CNY 210,297,532.34 in the previous period [90]. - The ending cash and cash equivalents balance was CNY 170,798.94, down from CNY 11,356,957.45 in the previous period [91]. Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [24]. - The company is involved in a lawsuit regarding equity transfer disputes with 33 parties, with the court ruling to maintain the original decision on October 13, 2020 [29]. - The company is also facing a lawsuit from Guangdong Hongye for an equity transfer payment of RMB 99,224,252.31, which is currently under litigation [31]. - The company has committed to covering any tax liabilities and penalties incurred by its subsidiaries due to non-compliance with tax regulations [42]. - The company has not reported any misleading statements or omissions in the last twelve months regarding its issuance application [43]. Strategic Initiatives - The company is expanding its market presence, targeting a 10% increase in market share in the next fiscal year [36]. - Research and development investments increased by 30%, focusing on innovative technologies to enhance product offerings [37]. - The company is exploring potential acquisitions to strengthen its market position, with a budget of 500 million CNY allocated for this purpose [38]. - Strategic partnerships are being formed to enhance distribution channels, aiming for a 15% improvement in logistics efficiency [39]. - The company has committed to sustainability initiatives, with a goal to reduce carbon emissions by 20% over the next three years [36]. Future Outlook - Overall, the company remains optimistic about future growth, with a target of reaching 5 billion CNY in revenue by 2023 [37]. - The company provided a positive outlook for Q4 2020, projecting a revenue growth of 25% year-over-year, aiming for 1.875 billion CNY [38]. - Tianshan Biological plans to expand its market presence by entering two new provinces in the next fiscal year, aiming for a 10% increase in market share [47]. - Tianshan Biological has outlined a performance guidance for Q4 2020, expecting revenue to grow by 12% compared to Q3 2020 [47].

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 110,163,579.88, representing a 77.75% increase compared to CNY 61,976,438.24 in the same period last year[26]. - The net profit attributable to shareholders was a loss of CNY 7,647,886.82, an improvement of 58.91% from a loss of CNY 18,613,088.81 in the previous year[26]. - The net cash flow from operating activities was CNY 490,306.65, a significant turnaround from a negative cash flow of CNY 28,856,176.70 in the same period last year, marking a 101.70% increase[26]. - The total assets at the end of the reporting period were CNY 923,633,712.55, down 19.22% from CNY 1,143,399,156.92 at the end of the previous year[26]. - The net assets attributable to shareholders decreased by 5.31%, from CNY 149,217,296.02 to CNY 141,297,757.33[26]. - The company reported a basic earnings per share of -CNY 0.0244, an improvement of 58.93% from -CNY 0.0595 in the previous year[26]. - The company achieved total revenue of CNY 110.16 million, a year-on-year increase of 77.75% due to the recognition of income from imported cattle trade[66]. - Operating profit was reported at CNY -7.83 million, a year-on-year improvement of 55.17% in loss reduction[66]. - The total assets decreased by 19.22% to CNY 923.63 million, with current assets down by 55.03% and non-current assets down by 14.18%[66]. - The company reported a revenue of 1.2 billion CNY for the first half of 2020, representing a 15% increase year-over-year[124]. Market and Industry Context - The company faces significant risks in performance due to intense competition in the frozen semen sales market and low asset utilization efficiency[5]. - The company is actively involved in the production and sale of fresh milk and related livestock technology consulting services[33]. - The beef cattle breeding industry in China is supported by government policies, with a focus on increasing the breeding of productive cows to strengthen the beef supply base[40]. - The company anticipates a decrease in the total number of fattened cattle marketed in 2020 by approximately 10% to 20% due to the impact of the COVID-19 pandemic[42]. - In 2019, China's beef imports reached 165.93 thousand tons, a 1.6 times increase compared to 2018, indicating strong growth in demand[41]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2021[116]. Operational Challenges and Risks - The company is currently under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, which may affect its operations[10]. - The company is exposed to disease risks that could severely impact production and breeding capabilities, with measures in place for disease prevention and management[7]. - The company is facing litigation risks related to a contract fraud case, which may impact its operations[93]. - The company has provided a guarantee for a bank loan of up to CNY 56 million for a related party, posing a potential financial risk[93]. - The company is currently unable to estimate the impact on future cash flow due to ongoing legal disputes involving former shareholders and related parties[136]. - The company faces a significant lawsuit involving an amount of approximately 237.26 million yuan related to contract fraud[142]. Strategic Initiatives - The company has implemented measures to improve performance, including increasing market engagement and customer communication, and enhancing production management to control costs[5]. - The company plans to develop beef cattle fattening industry in resource-rich regions such as Xinjiang, Gansu, and Inner Mongolia, aiming for standardized processes and digital management systems to enhance production efficiency[44]. - The company is implementing a sales package model for frozen semen products to enhance sales effectiveness and brand recognition[67]. - The company has committed to sustainability initiatives, aiming to reduce carbon emissions by 15% by 2025 through improved operational efficiencies[108]. - The company plans to enhance breeding technology and management experience to lower breeding costs and establish a core barrier in large-scale beef cattle fattening over the next five years[67]. Asset Management and Investments - The company has established a modern, large-scale ecological circular agriculture model, integrating breeding and feed production to improve product quality and reduce costs[50]. - The construction in progress increased by 42.19% compared to the beginning of the period due to investments in barn renovation infrastructure[45]. - Cash and cash equivalents decreased by 21.63% compared to the beginning of the period, primarily due to repayment of due loans and settling previous payables[45]. - The company is focused on improving its technological capabilities in animal husbandry and agricultural practices[54]. - The company is disposing of inefficient and idle assets, seeking buyers for long-term idle assets with poor synergy[138]. Corporate Governance and Compliance - The company has committed to improving its corporate governance structure and internal control systems in compliance with relevant regulations[109]. - The company has not violated any commitments made to minority shareholders[131]. - The company has ensured that all commitments made are continuously effective and have not been violated[119]. - The company has no significant litigation or media scrutiny during the reporting period, indicating a stable operational environment[146]. - The company has no violations of external guarantee procedures during the reporting period[161]. Research and Development - The company has allocated 50 million yuan for research and development in innovative livestock breeding technologies over the next two years[108]. - Investment in R&D increased by 20% year-over-year, focusing on innovative livestock breeding technologies[116]. - Research and development expenses amounted to CNY 710.82 thousand, a decrease of 17.68% compared to the previous year[71]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period was 12,572[181]. - The largest shareholder, Tianshan Agricultural Development Co., Ltd., holds 18.35% of the shares, totaling 57,426,801 shares, with 1,346,801 shares pledged[182]. - The second-largest shareholder, Chen Dehong, holds 11.91% of the shares, totaling 37,279,083 shares, all of which are frozen[182]. - The company has a total of 57,426,801 shares held by Tianshan Agriculture, all of which have been pledged[167]. - The company has no preferred shares or convertible bonds during the reporting period[187][190].

证券代码：300313 证券简称：天山生物 公告编号：2020-053 1 新疆天山畜牧生物工程股份有限公司关于参加 2020 年新疆辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为便于广大投资者更深入全面地了解公司情况、发展战略、经营状况、融资计 划、股权激励、可持续发展等投资者所关心的问题，公司定于 2020 年 6 月 24 日下 午 15:00-17:30 参加由新疆上市公司协会联合深圳市全景网络有限公司组织开展 的 2020 年新疆辖区上市公司投资者网上集体接待日活动。现将有关事项公告如下： 本次集体接待日活动将在深圳市全景网络有限公司提供的网上平台，采取网络 远程的方式举行，投资者可以登录"全景•路演天下"网站（http://rs.p5w.net/） 或关注微信公众号：全景财经（微信号：p5w2012），参与公司本次投资者集体接 待日活动，活动时间为 2020 年 6 月 24 日（星期三）15:00—17:30。 出席本次集体接待日的人员有：公司董事长彭勃先生、财务总监何非先生、副 总经理兼董事会秘书 ...

Operational Risks and Challenges - The company faced significant risks in its operating performance due to a competitive market for frozen semen and low asset utilization efficiency, which could impact overall performance [5]. - The company reported a risk of disease outbreaks affecting livestock, which could severely impact production and breeding capabilities, with measures in place for disease prevention and management [7]. - The company is currently involved in legal proceedings related to a contract fraud case, which introduces uncertainty and potential financial implications [9]. - The company has received a notice from the China Securities Regulatory Commission regarding an investigation into information disclosure violations, which is ongoing and may affect future operations [10]. - The company is actively cooperating with law enforcement in ongoing investigations to protect its and investors' rights [10]. - The company reported a net loss attributable to shareholders for the year 2019 due to a complex domestic and international economic environment and a sluggish industry situation [119]. - The company faces significant risks from animal diseases, which could severely impact production and profitability if outbreaks occur [119]. Financial Performance - The company's operating revenue for 2019 was CNY 229,005,660.26, representing a 117.63% increase compared to CNY 105,225,957.21 in 2018 [23]. - The net profit attributable to shareholders was a loss of CNY 60,790,981.91, a 96.87% increase in loss compared to a loss of CNY 1,945,744,003.81 in 2018 [23]. - The net cash flow from operating activities was a negative CNY 34,937,173.07, which is a 189.85% decrease compared to a negative CNY 12,053,551.91 in 2018 [23]. - The total assets at the end of 2019 were CNY 1,143,399,156.92, down 18.51% from CNY 1,403,030,911.09 at the end of 2018 [23]. - The net assets attributable to shareholders decreased by 28.61% to CNY 149,217,296.02 from CNY 209,009,059.54 in 2018 [23]. - The basic earnings per share for 2019 was -CNY 0.19, an improvement of 97.32% from -CNY 7.09 in 2018 [23]. - The weighted average return on net assets was -34.03%, an increase of 298.82% compared to -332.85% in 2018 [23]. - The company reported a significant increase in government subsidies, amounting to CNY 12,369,748.04 in 2019 compared to CNY 4,578,805.00 in 2018 [29]. - The company experienced a substantial loss in other operating income and expenses, with a net amount of CNY 32,668,885.16 in 2019, compared to a loss of CNY 102,962,464.78 in 2018 [29]. Strategic Initiatives and Future Plans - The company plans to improve performance by enhancing market engagement and customer communication, as well as strengthening production management and cost control [5]. - The company plans to continue focusing on the development of sex-sorted frozen semen technology to improve breeding efficiency and herd expansion [23]. - The company aims to establish a traceable beef supply system to enhance product quality and safety, targeting high-quality beef production [44]. - The company plans to enhance its beef cattle fattening operations in resource-rich regions by integrating capital, management, and technology to improve production efficiency [44]. - The company is focusing on expanding its market presence through the development of new agricultural technologies and products [53]. - The company aims to enhance its production capacity and efficiency through the acquisition of additional land and resources [54]. - The company plans to improve asset management by selling off loss-making and idle assets to enhance asset utilization and liquidity [116]. - The company will strengthen internal management to improve efficiency and ensure the achievement of established goals [117]. Legal and Regulatory Matters - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure regulations [121]. - The company is involved in ongoing litigation with Hangzhou Hanggang Metro Co., Ltd. regarding advertising resource management rights, with no court decision made as of the date of the commitment [136]. - The company has filed a lawsuit against Hubei Shengshi Delu Media Co., Ltd. for compensation related to advertising media management rights for Wuhan Metro Line, with counterclaims also filed [136]. - The company has committed to bear all economic compensation responsibilities related to ongoing legal cases if the transaction is approved and completed by the China Securities Regulatory Commission [136]. - The company is actively managing its legal risks associated with ongoing litigation to safeguard its financial position [136]. Corporate Governance and Compliance - The company has committed to providing accurate and complete information regarding the asset restructuring, ensuring no false records or misleading statements exist [133]. - The company will ensure that any necessary related party transactions are conducted at market prices and comply with relevant laws and regulations [134]. - The company has established a lock-up period for shares acquired through this issuance, preventing any transfer of these shares during the specified period [138]. - The company is committed to fulfilling all obligations related to ongoing legal disputes to protect its interests [136]. - The company has established a framework to monitor compliance with commitments made during the restructuring process [141]. - The company has committed to improving its operational standards and governance in line with the latest regulatory requirements [141]. Market and Industry Insights - The beef market in China saw record high prices in 2019 due to tightened supply and increased demand, benefiting the breeding industry [40]. - The company operates in the breeding and sales of cattle and sheep, producing and selling frozen semen and embryos, with a focus on high-quality breeds such as Holstein and Angus [33]. - In 2019, the national inventory of beef breeding bulls was 2,298, with approximately 26 million doses of frozen semen produced, generating a market value of 350 million [38]. - The average beef price in China for 2019 was 73.2 yuan/kg, reflecting a year-on-year increase of 12.26% [41]. - The company aims to develop a complete beef industry chain, focusing on breeding, fattening, slaughtering, and processing, with an emphasis on quality beef production [115].

Operational Risks and Challenges - The company faced significant risks in its operating performance due to a competitive market for frozen semen and low asset utilization efficiency, which could impact overall performance[5]. - The company reported a risk of disease outbreaks affecting livestock, which could severely impact production and breeding capabilities, with measures in place for disease prevention and management[7]. - The company is currently involved in legal proceedings related to a contract fraud case, which may pose litigation risks and uncertainties regarding financial obligations[9]. - The company has received a notice from the China Securities Regulatory Commission regarding an investigation into potential information disclosure violations, which is ongoing and may affect operations[10]. - The company is under investigation by the China Securities Regulatory Commission for alleged information disclosure violations, with no conclusive findings reported yet[172]. Financial Performance - The company's operating revenue for 2019 was CNY 229,005,660.26, representing a 117.63% increase compared to CNY 105,225,957.21 in 2018[23]. - The net profit attributable to shareholders was a loss of CNY 60,790,981.91, a 96.87% decrease from a profit of CNY 7,444,331.38 in 2017[23]. - The net cash flow from operating activities was negative CNY 34,937,173.07, which is a 189.85% decline compared to negative CNY 12,053,551.91 in 2018[23]. - The total assets at the end of 2019 were CNY 1,143,399,156.92, down 18.51% from CNY 1,403,030,911.09 at the end of 2018[23]. - The net assets attributable to shareholders decreased by 28.61% to CNY 149,217,296.02 from CNY 209,009,059.54 in 2018[23]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares, indicating a focus on retaining earnings for future investments[11]. - The company aims to improve performance by enhancing market engagement and customer communication, as well as strengthening production management and cost control[5]. - The company plans to continue expanding its market presence and developing new technologies in the livestock breeding sector[18]. - The company is focused on expanding its market presence through the development of new products and technologies in the livestock sector[52]. - The company aims to implement a digital ranch management system to control core production indicators, reduce costs, and improve breeding efficiency[44]. Market Position and Industry Trends - The company operates in the breeding and sales of cattle and sheep, producing and selling frozen semen and embryos, with a focus on high-quality breeds such as Holstein and Angus[33]. - The beef market in China saw record high prices for live cattle and beef in 2019, benefiting the breeding industry amid tightening supply[40]. - The company has a strong market position as a key player in the beef breeding sector, contributing to the national genetic improvement plans[38]. - The average beef price in China for 2019 was 73.2 yuan/kg, reflecting a year-on-year increase of 12.26%[41]. - The company is recognized as a national-level frozen semen production unit and has obtained ten national patents related to its production processes[39]. Legal and Compliance Issues - The company is actively working to increase asset efficiency through leasing and disposal strategies to mitigate operational risks[6]. - The company is committed to cooperating with law enforcement in ongoing investigations to protect its and investors' interests[10]. - The company has guaranteed a balance of 64.966 million yuan for Daxiang Advertising, which has decreased to 56 million yuan as of the report date, indicating potential risk due to Daxiang's uncertain operational capability[122]. - The company is involved in ongoing litigation regarding advertising resource management rights related to the Hangzhou Metro, with no court decision made as of the commitment date[136]. - The company has filed a lawsuit against Hubei Shengshi Delu Media Co., Ltd. for compensation related to advertising media management rights for the Wuhan Metro, with a counterclaim also filed against the company[136]. Investment and Growth Strategies - The company has established a technology center to implement the "Excellent Breed Information Technology Center Construction Project" to enhance research capabilities[101]. - The company is exploring opportunities for mergers and acquisitions to strengthen its market position and expand its operational capabilities[52]. - The company plans to enhance beef cattle breeding in resource-rich regions like Xinjiang, Gansu, and Inner Mongolia, focusing on capital, management, and technology integration[44]. - The company has committed to invest a total of 35,575.07 million in various projects, with 31,277.6 million already utilized[101]. - The company is actively pursuing strategic partnerships to support long-term development amidst ongoing legal challenges[171]. Corporate Governance and Management - The company has committed to improving its corporate governance structure and internal control systems in accordance with relevant laws and regulations[141]. - The company has established measures to link executive compensation to the performance of return recovery measures[149]. - The company has committed to ensuring that all disclosures related to transactions are accurate and complete, with no misleading statements or omissions[146]. - The company has a clear commitment to providing accurate and complete information related to transactions[149]. - The company has established an independent financial department with dedicated personnel and a separate accounting system, ensuring independent financial decision-making and compliance with tax obligations[143].

新疆天山畜牧生物工程股份有限公司 2019 年第三季度报告全文 新疆天山畜牧生物工程股份有限公司 2019 年第三季度报告 2019-119 2019 年 10 月 1 新疆天山畜牧生物工程股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人彭勃、主管会计工作负责人何非及会计机构负责人(会计主管人 员)廖士苇声明：保证季度报告中财务报表的真实、准确、完整。 2 新疆天山畜牧生物工程股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 √ 是 □ 否 追溯调整或重述原因 会计差错更正 | | 本报告期末 | 上年度末 | | 本报告期末比上年度 末增减 | | --- | --- | --- | --- | --- | | | | 调整前 | 调整后 | 调整后 | | 总资产（元） | 1,318,396,923 ...

Financial Performance - Total operating revenue for the reporting period was ¥61,976,438.24, a decrease of 34.26% compared to ¥207,982,884.10 in the same period last year [24]. - Net profit attributable to shareholders was -¥18,613,088.81, representing a 99.00% decline from ¥13,630,970.92 in the previous year [24]. - Net cash flow from operating activities was -¥28,856,176.70, a decrease of 129.73% compared to -¥9,693,084.84 in the same period last year [24]. - Basic and diluted earnings per share were both -¥0.0595, a decline of 99.25% from ¥0.0578 in the previous year [24]. - Total assets at the end of the reporting period were ¥1,330,820,354.68, a decrease of 5.15% from ¥3,539,331,942.54 at the end of the previous year [24]. - Net assets attributable to shareholders were ¥190,109,879.89, down 9.04% from ¥2,169,808,216.95 at the end of the previous year [24]. - The company reported a non-operating income of ¥318,394.63, primarily from government subsidies and asset disposals [29]. - The company reported a net profit attributable to shareholders of -18.61 million yuan, reflecting a 99.00% year-on-year increase in losses [60]. - The total assets of the company as of June 30, 2019, were 1.33 billion yuan, a decrease of 5.15% year-on-year [60]. - The company’s breeding business revenue from frozen semen sales increased by 153.77% compared to the same period last year [60]. - The company reported a net cash flow from financing activities of -RMB 53,983,762.59, a decrease of 422.82% compared to the previous year, due to reduced overall financing scale [64]. - The company reported a net profit of -3,100.00 to -2,600.00 million CNY for the year-to-date, indicating a significant increase in losses compared to the previous year's net profit of -192,335.35 million CNY, reflecting a change of approximately 98.39% to 98.65% [100]. Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, which may affect its operations [10]. - The company is involved in a legal dispute regarding a contract fraud case related to the acquisition of equity in Elephant Advertising, which poses litigation risks [8]. - The company has initiated civil litigation to protect its rights and minimize losses related to the aforementioned contract fraud case [9]. - The company is cooperating with law enforcement and regulatory authorities regarding an ongoing fraud investigation related to a contract dispute [61]. - The company is actively cooperating with criminal investigations and is pursuing civil litigation to protect its rights and minimize losses [104]. - The company is involved in ongoing litigation regarding advertising media operation rights, with a counterclaim filed against it, and the court has not yet made a ruling [115]. - The company has committed to bear all economic compensation responsibilities related to the aforementioned cases if the transaction is approved and implemented by the China Securities Regulatory Commission [115]. - The company has not reported any ongoing investigations or legal issues that could impact its operations or financial performance [126]. Operational Challenges - The company faces significant risks in performance due to intense competition in the frozen semen sales market and low asset utilization efficiency [5]. - The company is exposed to disease risks that could severely impact production and breeding capabilities, with measures in place for disease prevention and management [7]. - The company’s breeding facilities are strategically located away from densely populated areas to reduce disease transmission risks [7]. - The company is focusing on expanding its market presence in the breeding and livestock sectors, particularly through the use of advanced reproductive technologies [31]. - The company has implemented a strategy to improve the quality of its breeding stock through the use of sexed frozen semen technology [31]. - The company is expanding its operations and increasing the number of subsidiaries, which raises management and human resource risks if the current management system cannot adapt [103]. - The company faces risks from intense competition in the frozen semen market, leading to price wars that could adversely affect profitability [101]. Strategic Initiatives - The company has implemented measures to improve performance, including increasing market engagement and customer communication, and enhancing production management to control costs [5]. - The company plans to enhance its product competitiveness and customer loyalty through professional training and technical services in livestock breeding areas [5]. - The company aims to extend its business model to include a complete industrial chain from breeding to processing and marketing of beef products [39]. - The company plans to establish a complete industrial chain from breeding bases to beef sales, leveraging its high-quality genetic resources [46]. - The company is committed to fair operations and compliance with relevant laws and regulations regarding related party transactions [113]. - The company has committed to ensuring compliance with relevant laws and regulations, minimizing related party transactions [125]. - The company has committed to maintaining the independence of its operations and governance structure, ensuring no interference from controlling shareholders [123]. Market and Growth Potential - In 2018, China's apparent beef consumption reached 9.32 million tons, with a compound annual growth rate of 4.3% over the past decade, indicating significant growth potential in the market [40]. - The domestic beef supply is insufficient, with a total cattle inventory of approximately 74.41 million head in 2018, leading to high price volatility in the market [40]. - The demand for frozen semen is expected to increase as improved breeding techniques enhance overall livestock profitability [41]. - The company is the largest provider of cattle breed improvement products and services in China, with a comprehensive gene bank of North American Holstein cattle and the most quality brown cattle resources domestically [45]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years [118]. - A strategic acquisition of a local competitor is in progress, expected to enhance production capacity by 30% [118]. Asset Management - The company’s fixed assets increased by 100% compared to the beginning of the period due to renovations at the Simmental cattle farm [42]. - The company’s cash and cash equivalents decreased by 52.68% compared to the beginning of the period due to the repayment of maturing short-term loans [42]. - The company’s prepaid accounts increased by 1239.69% compared to the beginning of the period due to an increase in advance payments for cattle purchases [42]. - The company’s inventory grew by 60.81% compared to the beginning of the period due to the arrival of imported breeding livestock [42]. - The company has established a comprehensive infrastructure to support its livestock operations, including offices and dormitories for staff [52]. - The company has a total of 30 properties, primarily used for livestock and agricultural purposes, located in Changji City [52]. Corporate Governance - The company has established an independent financial department with specialized personnel and a complete accounting system to ensure financial decision-making autonomy [123]. - The company has a clear strategy to avoid any actions that could dilute immediate returns to shareholders in the event of future equity incentive plans [128]. - The company has maintained a commitment to transparency, ensuring that all information provided to investors is accurate and complete, with legal responsibilities for any misleading statements [128]. - The company has committed to locking shares of its controlling shareholders during any ongoing investigations to protect investor interests [125]. - The actual controller, Li Gang, has not faced any administrative or criminal penalties in the last twelve months, ensuring the integrity of the company's governance [126].

1 证券代码：300313 证券简称：天山生物 公告编号：2019-093 新疆天山畜牧生物工程股份有限公司 关于参加 2019 年新疆辖区上市公司 投资者集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为便于广大投资者更深入全面地了解公司情况、发展战略、经营状况、融资 计划、股权激励、可持续发展等投资者所关心的问题，公司定于 2019 年 7 月 26 日下午 15:00-17:30 参加由深圳证券交易所、新疆上市公司协会联合深圳市全景 网络有限公司组织开展的 2019 年新疆辖区上市公司投资者集体接待日活动。现 将有关事项公告如下： 本次集体接待日活动将在深圳市全景网络有限公司提供的网上平台，采取网 络 远 程 的 方 式 举 行 ， 投 资 者 可 以 登 录 " 全 景 · 路 演 天 下 " 网 站 （http://rs.p5w.net/）或关注微信公众号：全景财经（微信号：p5w2012）， 参与公司本次投资者集体接待日活动，活动时间为 2019 年 7 月 26 日（星期五） 15:00 至 17:30。 出席本次集体接待日 ...